Clinical Trial Update: Doxorubicin in Treating Patients With AIDS-Related Kaposi's Sarcoma [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating doxorubicin for AIDS-related Kaposi's sarcoma has completed, according to the sponsor Roswell Park Cancer Institute.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kaposi Sarcoma

Drugs mentioned

• Doxorubicin (doxorubicin)

Snippet

Sponsor: Roswell Park Cancer Institute | Conditions: Sarcoma | Phase 3 | Status: COMPLETED